How Did STIC (Shanghai) Strengthen Its Medical Silicone Gel Technology Through the Guangxi Province Major Science and Technology Project?

STIC (Shanghai) Co., LTD. Leads Guangxi Province Major Science and Technology Project to Successful Completion, Elevating Core Technological Competitiveness to a New Level

STIC (Shanghai) Co., LTD. announced on August 27, 2026, the successful conclusion and official acceptance of the Guangxi Province Major Science and Technology Project titled "Research, Development, and Industrialization of Advanced New Material Medical Silicone Gel and Products." The multi-year initiative represents a significant milestone in the company's ongoing commitment to advancing medical-grade silicone technology through collaborative innovation.

The project was jointly undertaken by four leading organizations: STIC (Shanghai) Co., LTD., Guangxi University, Guangxi Minzu University, and Guangxi Province Institute of Traditional Chinese Medicine and Pharmacy. This industry-academia-research partnership brought together deep expertise in materials science, polymer chemistry, and traditional pharmaceutical research to accelerate breakthroughs in medical silicone gel formulation and production.

Three Years of Collaborative Innovation

After three years of intensive collaborative effort, the four participating parties successfully fulfilled all assessment indicators set for the project, achieving significant breakthroughs in both core technologies and industrial applications. The scope of work spanned fundamental research through to industrialization, ensuring that laboratory advances could be translated into scalable, commercially viable manufacturing processes.

The successful completion of this Major Science and Technology Project marks an important step forward for STIC in the areas of industry-university-research collaborative innovation and the commercialization of scientific and technological achievements. By combining the company's manufacturing and application expertise with the academic and research capabilities of its university and institute partners, STIC was able to pursue technical challenges that would be difficult to address through in-house R&D alone.

Strengthening Core Technological Competitiveness

This milestone has substantially strengthened STIC's core technological competitiveness in the field of polymer materials, with a specific focus on medical silicone gel. The advances achieved through the project lay a solid foundation for the company's future market expansion and industrial upgrading, positioning STIC to compete more effectively as global demand for advanced medical polymer materials continues to grow.

Medical silicone gel is a safe, hypoallergenic medical polymer material widely used across a range of healthcare applications, including scar management, wound care, prosthetics, and wearable medical devices. Its biocompatibility, flexibility, and skin-friendly properties have made it an increasingly preferred material choice among medical device manufacturers and healthcare providers seeking reliable, long-term solutions for patient care.

A Rapidly Expanding Global Market

The timing of this project's completion aligns closely with strong projected growth across the medical silicone sector. The global medical-grade silicone market is projected to grow from $2.0 billion in 2025 to $4.0 billion by 2035, while China's domestic medical silicone gel market is expected to reach $1.4 billion by 2033. These figures reflect rising demand for advanced wound care and scar management products, an aging global population, and continued innovation in wearable and implantable medical devices.

The successful completion of the Guangxi Province project positions STIC strategically to capitalize on these rapidly expanding market opportunities. With enhanced core technology and a strengthened research foundation, the company is well-placed to introduce next-generation medical silicone products to both domestic and international markets.

Applications Across Healthcare Sectors

The advanced new material medical silicone gel developed through this project has broad relevance across several healthcare application areas:

• Scar management products, including silicone gel sheets and topical gels used to reduce the appearance of surgical and traumatic scars
• Advanced wound care dressings that support moist wound healing environments while minimizing skin irritation
• Prosthetic liners and components that require durable, skin-safe materials capable of long-term contact with the body
• Wearable medical devices, where flexible, hypoallergenic silicone gel is essential for comfortable, extended wear

Looking Ahead: Continued Innovation and Partnership

While the Major Science and Technology Project has concluded, innovation at STIC continues without pause. The company will use the successful implementation of this project as a new starting point, deepening its university-industry partnerships and accelerating the commercialization of research outcomes. This approach reflects STIC's broader strategy of pairing sustained R&D investment with strong academic collaboration to drive high-quality development across the adhesive and medical silicone industry.

By building on the technological foundation established through this project, STIC aims to continue delivering enhanced technological strength to the market, supporting the next phase of growth in medical-grade silicone gel research, development, and industrialization.

About STIC (Shanghai) Co., LTD.

STIC (Shanghai) Co., LTD. specializes in medical-grade silicone gel products and is committed to advancing the research, development, and industrialization of high-performance medical-grade silicone adhesives. Through continuous innovation and strategic collaborations with leading academic institutions, the company strives to deliver cutting-edge solutions for the global healthcare market.